ARLENE ZWALD: Open Payments
NPI 1023128980 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 24 payments from 8 companies in 2025. Trend: 2023 $831 · 2024 $1,247 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $205 |
| Axsome Therapeutics, Inc. | 6 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| ABBVIE INC. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
Products named: UZEDY, Auvelity, COBENFY, REXULTI, VRAYLAR, AUSTEDO XR, SPRAVATO, Qelbree.
Industry payments across TX — which companies pay providers there.
